---
$id: https://graph.org.ai/products/commodity/51143207
$type: Product
source: UNSPSC
code: "51143207"
title: "Lobeline"
class: "51143200"
classTitle: "Anti abuse drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lobeline

**UNSPSC Code**: 51143207
**Class**: [Anti abuse drugs](Anti abuse drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a nicotinic agonist with the molecular formula C22H27NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D0P25S3P81, chemically known as 8,10-diphenyllobelionol but generally known as lobeline, which bears US NIH Compound Identifier 3945. European Medicines Agency schedules Lobeline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08541MIG. The term LOBELINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). LOBELINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lobeline under HS 29399900 and SITC 54149. As of Q4 2014, LOBELINE remains the US FDA Preferred Term for this commodity. Lobeline bears US NLM identifiers UMLS ID C0023929 and NCI Concept Code C93261. SMILES: OC(CC1N(C(CCC1)CC(=O)C1CCCCC1)C)C1CCCCC1.

